Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

7.36

0.00 (0.00%)

At close: Feb 2, 2026, 4:00 PM EST

7.57

+0.21 (2.82%)

After-hours: Feb 2, 2026, 7:40 PM EST

Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,221	505	325	181	365	-
Market Cap Growth	152.82%	55.70%	79.47%	-50.50%	-	-
Enterprise Value	1,387	707	487	226	360	-
Last Close Price	7.36	3.39	2.35	1.33	2.93	-
PS Ratio	4.32	2.49	1.98	1.64	7.37	-
PB Ratio	-	-17.07	-47.86	4.00	3.84	-
EV/Sales Ratio	5.21	3.48	2.97	2.05	7.26	-
Debt / Equity Ratio	-299.25	-9.17	-33.79	4.38	0.93	2.58
Asset Turnover	0.77	0.63	0.49	0.34	0.21	0.15
Inventory Turnover	0.73	0.85	0.90	1.06	1.01	1.77
Quick Ratio	1.25	1.12	1.17	2.08	1.52	4.99
Current Ratio	1.93	1.67	1.64	2.54	1.80	5.40
Return on Equity (ROE)	-	-	-324.20%	-134.83%	-190.28%	-378.20%
Return on Assets (ROA)	2.88%	-5.33%	-8.25%	-15.78%	-28.45%	-38.02%
Return on Capital Employed (ROCE)	6.30%	-12.40%	-19.40%	-30.20%	-46.80%	-62.30%
Earnings Yield	-1.28%	-10.85%	-19.18%	-52.34%	-33.59%	-
FCF Yield	0.82%	-7.49%	-15.18%	-57.18%	-26.44%	-
Buyback Yield / Dilution	-8.48%	-6.61%	-1.51%	-71.62%	-85.32%	-63.32%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q